Dean Petkanas - 05 Jan 2022 Form 4 Insider Report for NEUROPATHIX, INC.

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Dean Petkanas
Issuer symbol
N/A
Transactions as of
05 Jan 2022
Net transactions value
-$12,189
Form type
4
Filing time
07 Jan 2022, 16:22:20 UTC
Previous filing
02 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPTX Common Stock Sale $4,183 -89,000 -0.36% $0.0470 24,770,029 05 Jan 2022 See Note F1, F2, F3, F4
transaction NPTX Common Stock Sale $6,120 -120,000 -0.48% $0.0510* 24,650,029 06 Jan 2022 See Note F1, F2, F4, F5
transaction NPTX Common Stock Sale $1,886 -41,000 -0.17% $0.0460 24,609,029 07 Jan 2022 See Note F1, F4
transaction NPTX Common Stock Gift $0 -300,000 -1.2% $0.000000 24,309,029 07 Jan 2022 See Note F4, F6
transaction NPTX Common Stock Gift $0 -250,000 -1% $0.000000 24,059,029 07 Jan 2022 See Note F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person.
F2 These shares were sold in multiple transactions at prices falling within those ranges set forth in footnotes (3) and (5) of this Form 4. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the relevant footnotes.
F3 These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive.
F4 These shares were sold in multiple transactions at prices ranging from $0.045 to $0.050, inclusive.
F5 Aggregate amount of shares beneficially owned by the reporting person includes shares held by him directly as well as indirectly through Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC. The reporting person disclaims beneficial ownership of the securities held by Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC, except to the extent of his pecuniary interest therein.
F6 Represents a gift of shares by Golden Gate Capital Partners, LLC.